Cargando…

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis

Background. Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with ineffective treatment. Mycophenolate mofetil (MMF) is an immunomodulatory agent which inhibits lymphocyte proliferation. Objective. We sought to determine the safety and efficacy profile of MMF i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzouvelekis, Argyris, Bouros, Evangelos, Oikonomou, Anastasia, Ntolios, Paschalis, Zacharis, George, Kolios, George, Bouros, Demosthenes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206363/ https://www.ncbi.nlm.nih.gov/pubmed/22135741 http://dx.doi.org/10.1155/2011/849035

Ejemplares similares

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Idiopathic Pulmonary Hemosiderosis in Adults: A Case Report and Review of the Literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
por: Tzilas, Vasilios, et al.
Publicado: (2017)

Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004)

Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars
por: Tzouvelekis, Argyris, et al.
Publicado: (2019)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
por: Nambiar, Anoop M., et al.
Publicado: (2017)

Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Acute fibrinous and organising pneumonia: a case report and review of the literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006)

Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

HbA(1c) is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
por: Papanas, Nikolaos, et al.
Publicado: (2009)

Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
por: Antoniou, Katerina, et al.
Publicado: (2020)

Chemotherapy-induced changes in bronchoalveolar lavage fluid CD4 + and CD8 + cells of the opposite lung to the cancer
por: Karpathiou, Georgia, et al.
Publicado: (2020)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004)

False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2020)

Telomeropathy in Chronic Hypersensitivity Pneumonitis
por: Bouros, Demosthenes, et al.
Publicado: (2019)

Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
por: Tzilas, Vasilios, et al.
Publicado: (2020)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations
por: Kishore, Amit, et al.
Publicado: (2016)

Predictors of obstructive sleep apnea in males with metabolic syndrome
por: Papanas, Nikolaos, et al.
Publicado: (2010)

Idiopathic membranoproliferative glomerulonephritis treated with mycophenolate mofetil
por: Koratala, Abhilash, et al.
Publicado: (2018)

Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2022)

Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
por: Malli, Foteini, et al.
Publicado: (2019)

The Management of Patients With Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2018)

Acute effect of smoking on plasma Obestatin levels
por: Kukuvitis, Asterios, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p3qbfa4u5vcabf8lndh7kd4ov2